MIOCHOL-E
Details
- Status
- Prescription
- First Approved
- 1993-09-22
- Routes
- OPHTHALMIC
- Dosage Forms
- FOR SOLUTION
MIOCHOL-E Approval History
What MIOCHOL-E Treats
1 indicationsMIOCHOL-E is approved for 1 conditions since its original approval in 1993. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Chest Congestion
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
MIOCHOL-E FDA Label Details
ProIndications & Usage
FDA Label (PDF)INDICATIONS: May temporarily relieve symptoms associated with reactions to actylcholine chloride, such as chest congestion with mild constriction. ** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.